Cyclo Therapeutics, Inc.
CYTH
$0.7206
$0.00991.39%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -24.80M | -20.74M | -19.39M | -20.06M | -19.40M |
| Total Depreciation and Amortization | 11.40K | 14.00K | 16.60K | 19.20K | 19.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.31M | 1.77M | 975.30K | 789.80K | 613.60K |
| Change in Net Operating Assets | -1.04M | 583.10K | 404.40K | 3.06M | 4.13M |
| Cash from Operations | -22.52M | -18.37M | -18.00M | -16.19M | -14.64M |
| Capital Expenditure | -2.40K | -2.40K | -2.40K | -2.40K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -2.40K | -2.40K | -2.40K | -2.40K | 0.00 |
| Total Debt Issued | 10.00M | 2.00M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 2.90M | 7.90M | 10.79M | 12.13M | 9.23M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 8.75M | 8.75M | 9.28M | 11.76M | 2.92M |
| Cash from Financing | 21.65M | 18.65M | 20.08M | 23.89M | 12.15M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -873.80K | 280.30K | 2.08M | 7.70M | -2.49M |
